tadalafil has been researched along with ass234 in 1 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (ass234) | Trials (ass234) | Recent Studies (post-2010) (ass234) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 9 | 0 | 9 |
| Protein | Taxonomy | tadalafil (IC50) | ass234 (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.35 | |
| Cholinesterase | Homo sapiens (human) | 2.092 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.043 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.0052 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.0169 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.0933 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.8093 | |
| Beta-secretase 1 | Homo sapiens (human) | 0.46 | |
| Cholinesterase | Equus caballus (horse) | 0.46 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, J; Xu, S; Zhang, P; Zhu, Z | 1 |
1 review(s) available for tadalafil and ass234
| Article | Year |
|---|---|
Multi-target design strategies for the improved treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Chelating Agents; Clinical Trials as Topic; Enzyme Inhibitors; Humans; Neuroprotective Agents; Nootropic Agents; Receptors, Cell Surface; Signal Transduction | 2019 |